Outlook Therapeutics Inc
NASDAQ:OTLK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
US |
|
Heidelberg Pharma AG
XETRA:HPHA
|
DE |
|
J&T Global Express Ltd
F:J92
|
CN |
|
R
|
Rockfire Resources PLC
F:P2P
|
UK |
|
C
|
Cushman & Wakefield PLC
F:2IY
|
UK |
|
Evolution AB (publ)
STO:EVO
|
SE |
|
Investor AB
F:IVS
|
SE |
|
C
|
Champion Pacific Indonesia Tbk PT
SWB:IUD
|
ID |
|
B
|
Boyd Gaming Corp
F:BO5
|
US |
|
Jackson Financial Inc
F:8WF
|
US |
|
P
|
Pennantpark Investment Corp
F:12P
|
US |
|
Pebblebrook Hotel Trust
NYSE:PEB
|
US |
|
N
|
Nextdoor Holdings Inc
NYSE:KIND
|
US |
|
N
|
Nuvalent Inc
NASDAQ:NUVL
|
US |
|
A
|
Anthem Inc
F:A58
|
US |
|
U
|
Unisys Corp
DUS:USY1
|
US |
|
F
|
Fast Retailing Co Ltd
OTC:FRCOY
|
JP |
|
A
|
Avex Inc
F:AX8
|
JP |
|
Dell Technologies Inc
NYSE:DELL
|
US |
Wall St Price Targets
OTLK Price Targets Summary
Outlook Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for OTLK is 5.61 USD with a low forecast of 0.51 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OTLK's stock price target?
Price Target
5.61
USD
According to Wall Street analysts, the average 1-year price target for OTLK is 5.61 USD with a low forecast of 0.51 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Outlook Therapeutics Inc?
Projected CAGR
55%
Over the last 10 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 55%.
What is the Gross Profit forecast for Outlook Therapeutics Inc?
Projected CAGR
558%
The compound annual growth rate for Gross Profit over the next 3 years is 558%.
